Package 16571-786-01

{"route": ["ORAL"], "spl_id": "5796d926-9887-452b-a432-ebd3d32ddd10", "openfda": {"nui": ["N0000175753", "N0000008486", "N0000175751", "N0000187061", "N0000000191"], "upc": ["0316571785018"], "unii": ["U3H27498KS"], "rxcui": ["311264", "311265"], "spl_set_id": ["f54690b3-bcbb-4d94-95b9-b7591af00117"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]", "Mood Stabilizer [EPC]"], "pharm_class_moa": ["Organic Cation Transporter 2 Inhibitors [MoA]", "Dihydrofolate Reductase Inhibitors [MoA]"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, CHEWABLE in 1 BOTTLE (16571-786-01)", "package_ndc": "16571-786-01", "marketing_start_date": "20091104"}], "brand_name": "Lamotrigine", "product_id": "16571-786_5796d926-9887-452b-a432-ebd3d32ddd10", "dosage_form": "TABLET, CHEWABLE", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]", "Dihydrofolate Reductase Inhibitors [MoA]", "Mood Stabilizer [EPC]", "Organic Cation Transporter 2 Inhibitors [MoA]"], "product_ndc": "16571-786", "generic_name": "Lamotrigine", "labeler_name": "Rising Pharma Holdings, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lamotrigine", "active_ingredients": [{"name": "LAMOTRIGINE", "strength": "25 mg/1"}], "application_number": "ANDA090401", "marketing_category": "ANDA", "marketing_start_date": "20091104", "listing_expiration_date": "20261231"}